Hint mode is switched on Switch off
For swift navigation between sections

Domestic bonds: MGI Pharma, 0% 2mar2024, USD (7121D)
US552880AB28

  • Placement amount
    348,000,000 USD
  • Outstanding amount
    348,000,000 USD
  • Denomination
    1,000 USD
  • ISIN
    US552880AB28
  • CFI
    DCFUGR
  • FIGI
    BBG000934HG4
  • Ticker
    EISAI 1.6821 03/02/24

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access
×

— Are you looking for complete & verified bond data?

— We have everything
you need:

  • full data on over 700 000 bonds, stocks & ETFs;
  • powerful bond screener;
  • over 350 pricing sources among stock exchanges & OTC market;
  • ratings & financial reports;
  • user-friendly interface;
  • available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 652K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Files

Prospectus

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Bond is not traded; the issue is redeemed
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
Customize fields in the table
Found:
Show all fields
* Data is not available within the selected subscription
Quotes from market participants are indicative

Stock exchange and OTC quotes

Issue information

Profile
MGI Pharma, Inc., a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products for oncology and acute care applications. The company markets Aloxi (palonosetron hydrochloride) Injection, Dacogen (decitabine) for Injection, and Gliadel Wafer (polifeprosan 20 with carmustine ...
MGI Pharma, Inc., a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products for oncology and acute care applications. The company markets Aloxi (palonosetron hydrochloride) Injection, Dacogen (decitabine) for Injection, and Gliadel Wafer (polifeprosan 20 with carmustine implant) in the United States. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets. The company was formerly known as Molecular Genetics, Inc. and changed its name to MGI Pharma, Inc. in January, 1990. The company was founded in 1979 and is headquartered in Bloomington, Minnesota. It has facilities in Bloomington, Minnesota; Lexington, Massachusetts; and Baltimore, Maryland. As of January 25, 2008, MGI Pharma, Inc. operates as a subsidiary of Eisai Corporation of North America, Inc.
  • Issuer
    Go to the issuer page
    MGI Pharma
  • Full borrower / issuer name
    MGI Pharma
  • Sector
    Corporate
  • Industry
    Miscellaneous Healthcare: Products and Services
Volume
  • Placement amount
    348,000,000 USD
  • Outstanding amount
    348,000,000 USD
Nominal
  • Nominal
    1,000 USD
  • Outstanding face value
    *** USD
  • Integral multiple
    *** USD

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***
  • Early redemption date
    ***

Early redemption terms

***

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access
×

— Are you looking for complete & verified bond data?

— We have everything
you need:

  • full data on over 700 000 bonds, stocks & ETFs;
  • powerful bond screener;
  • over 350 pricing sources among stock exchanges & OTC market;
  • ratings & financial reports;
  • user-friendly interface;
  • available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 652K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Placement
    ***
  • Initial issue price (yield)
    (***%)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
Participants
  • Depository
    ***

Conversion and exchange

  • Initial premium
    ***%
  • Convertible until
    ***
  • Conversion terms
    ***

Additional information

***

Identifiers

  • ISIN
    ***
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • CFI
    DCFUGR
  • FIGI
    BBG000934HG4
  • WKN
    A0DG8J
  • Ticker
    EISAI 1.6821 03/02/24
  • Type of security by CBR
    ***

Bond classification

  • Senior Subordinated Unsecured
  • Registered
  • Coupon bonds
  • Convertible
  • Subordinated
  • Trace-eligible
  • Amortization
  • Callable
  • CDO
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Sukuk

Restructuring

***

Registration is required to get access.